|
|
||||||||
European Journal of Cardio-Thoracic Surgery, Vol 8, 470-476, Copyright © 1994 by European Association for Cardio-thoracic Surgery
M Grabenwoger, M Grimm, C Leukauf, C Szeles, E Feichtinger, MM Muller, A Moritz, P Bock and E Wolner
Between February 1986 and February 1992, 144 patients (mean age 69 years)
received 149 bovine pericardial valve bioprostheses (Sorin Pericarbon). Out
of this group 10 patients required reoperation because of valvular
dysfunction. Defect bioprostheses (7 aortic valves, 3 mitral valves),
removed 34 to 81 months after implantation, were studied by X-ray analysis
as well as light and electron microscopy. Seven out of ten valves were
explanted because of valvular stenosis, two valves had to be replaced
because of valvular regurgitation and one because of paravalvular leakage.
X-ray analysis revealed severe clacification of the cusps in all cases.
Mineralization occurred predominantly next to commissural attachment zones.
Cuspal tearing, associated with calcific degeneration of the tissue, was
observed in two cases. Beside the commissures, accelerated tissue
degeneration could be detected near the basal suture line: disintegration
of collagen bundles by invading macrophages and mineral deposits was
prominent in these regions. Scanning electron microscopy revealed the
presence of circumscribed areas of endothelial-like cell lining on both
surfaces of the cusps of five explants. Valvular stenosis, caused by severe
calcification of commissural as well as basal regions of the leaflets, is
the principal failure mode of the Sorin Pericarbon heart valve prostheses.
As an additional aspect, the basal suture line must be assumed to be a
critical determinant in accelerating tissue degeneration. Long-term
clinical studies will be required to evaluate the clinical performance of
this valve, focusing on thromboembolic complications, hemodynamic function
and long-term durability.
ARTICLES
Failure mode of a new pericardial valve prosthesis (Sorin Pericarbon). A morphological study
Second Department of Surgery, University of Vienna, Austria.
This article has been cited by other articles:
![]() |
D. D. Potter, T. M. Sundt III, K. J. Zehr, J. A. Dearani, R. C. Daly, C. J. Mullany, C. G. A. McGregor, F. J. Puga, H. V. Schaff, and T. A. Orszulak Risk of repeat mitral valve replacement for failed mitral valve prostheses Ann. Thorac. Surg., July 1, 2004; 78(1): 67 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Murday, A. Hochstitzky, J. Mansfield, J. Miles, B. Taylor, E. Whitley, and T. Treasure A prospective controlled trial of st. jude versus starr edwards aortic and mitral valve prostheses Ann. Thorac. Surg., July 1, 2003; 76(1): 66 - 73. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Le Tourneau, C. Savoye, E. P. McFadden, D. Grandmougin, H.-F. Carton, J.-L. Hennequin, A. Dubar, G. Fayad, and H. Warembourg Mid-Term Comparative Follow-Up After Aortic Valve Replacement with Carpentier-Edwards and Pericarbon Pericardial Prostheses Circulation, November 9, 1999; 100(90002): II-11 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Borowiec, T. W. Dubiel, H.-E. Hansson, J. Landelius, S.-O. Nystrom, and J. W. Borowiec Pericarbon Pericardial Valve Prosthesis: Midterm Results of the Aortic Valve Replacement Angiology, January 1, 1998; 49(1): 1 - 11. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |